Consistent results were also found in the GSE16011 dataset, in which higher SERINC2 expression predicted poor 5-, 10-, and 15-year OS in LGG patients (Fig. 2e–g), but no significant results were found in GBM patients (Fig. 2h). The gene discussed is SERINC2; the disease is glioblastoma.